McGill

Patents and Medical Research

Classified as: McGill, Richard Gold, BFM

Category:

In the Headlines

Published on: 25 Feb 2015

McGill group leaves to tour emerging economic region

Classified as: Karl Moore, McGill, Northeast Public Radio

Category:

In the Headlines

Published on: 25 Feb 2015

Special report: examining the blackface debate

Classified as: McGill, ctv news, Charmain Nelson

Category:

In the Headlines

Published on: 25 Feb 2015

Homéopathie: une pilule bien dorée

Classified as: ariel fenster, McGill, La Presse

Category:

In the Headlines

Published on: 25 Feb 2015

Being comfortable with science in our everyday lives

Classified as: Joe Schwarcz, science, McGill, Real Agriculture

Category:

In the Headlines

Published on: 25 Feb 2015

L'homéopathie contre la rougeole?

Classified as: ariel fenster, McGill, Radio Canada

Category:

In the Headlines

Published on: 18 Feb 2015

Why corporate social responsibility is evolving

Classified as: Karl Moore, McGill, the globe and mail, Christopher Marquis, Corporate

Category:

In the Headlines

Published on: 18 Feb 2015

Suicide's painful aftershocks

Classified as: McGill, suicide, The Montreal Gazette

Category:

In the Headlines

Published on: 18 Feb 2015

Teens needed for dairy study at Macdonald College

Classified as: science, McGill, The Montreal Gazette, dairy, Mcdonald College

Category:

In the Headlines

Published on: 18 Feb 2015

Ronald Hilaire named McGill's head football coach

Classified as: McGill, football, The Montreal Gazette, Coach, Ronald Hilaire

Category:

In the Headlines

Published on: 18 Feb 2015

New hope in the fight against pain

An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.